Independent of accreditation, third-party potency and sterility testing provides batch-level verification
Tirzepatida tambin provoc una mayor prdida de peso que semaglutida

Do Not Use Zepbound If You Have a personal or family history of medullary thyroid carcinoma Have Multiple Endocrine Neoplasia syndrome type 2 Have had a serious allergic reaction to tirzepatide or any of the ingredients in Zepbound Warnings and Precautions Severe gastrointestinal disease not recommended for patients with severe gastroparesis Acute pancreatitis Acute gallbladder disease Hypoglycemia with concomitant insulin or insulin secretagogue use Hypersensitivity reactions including anaphylaxis and angioedema Acute kidney injury Diabetic retinopathy complications in patients with a history of diabetic retinopathy Suicidal behavior and ideation monitor for new or worsening depression or unusual mood changes Pulmonary aspiration during general anesthesia or deep sedation delayed gastric emptying may increase aspiration risk Most Common Adverse Reactions Nausea, diarrhea, vomiting, constipation Abdominal pain and dyspepsia Injection site reactions Fatigue Hypersensitivity reactions Eructation, hair loss, gastroesophageal reflux disease Hormonal Contraception Interaction Zepbound may reduce the effectiveness of oral hormonal contraceptives

It is essential to work with your GP to monitor your TSH levels every few weeks during the initial phases of weight loss to avoid becoming hyperthyroid
PPPY, per patient per year
Wegovy contains a higher dose of semaglutide than Ozempic and is FDA-approved specifically for weight loss